2026-01-122026-01-122024Karabay, C. Y., Taşolar, H., Kunak, A. Ü., Çap, M., Astarcıoglu, M. A., Sen, T., Kaplan, M., Coşgun, M. S., Vatansever, F., Arslan, U., Acıksarı, G., Er, F., Mert, K. U., Ozdogan, O., Calıskan, S., Akşıt, E., Yılmaz, A. S., Aksakal, E., Sımsek, Z., Efe, S., Akture, G., Boyuk, F., Basaran, O., Ballı, M., Aslan, A. O., Güler, G. B., Batgerel, U., Ozkalaycı, F., Kaya, B. C., Kanar, B. G., Karakayalı, M., Erdogan, E., İş, G., Kalkan, S., Demırel, S., Aksu, U., Guray, U., Bas, H., Gök, M., Yılmaz, M., Şımşek, B., Kolak, Z., Öz, M., Ulukoksal, U., Kuloğlu, H. E., Cabuk, G., Köksal, F., Nızam, A. C., Çoldur, R., Şaylık, F., Tanboga, I. H. (2024). Turkish Real Life Atrial Fibrillation İn Clinical Practice: Traffıc Study. The Anatolian Journal Of Cardiology , 28(2), 87 - 93. Doi.Org/10.14744/Anatoljcardiol.2023.36162149-2263https://hdl.handle.net/11616/106309In the general adult population, atrial fibrillation (AF), which affects 2% of people, is the most prevalent sustained cardiac arrhythmia.1A systematic review that included 184 population-based studies from around the world estimated that 33.5 million people had AF in 2010. However, the global prevalence of AF is thought to be much higher due to the scarcity of data from regions outside of Europe and North America and undiagnosed subclinical cases of AF.2More than 6 million people have been diagnosed with AF in Europe alone, and the prevalence of the condition is expected to at least double over the next 50 years as the population ages. To determine the prevalence, progression, and mortality of chronic AF in the Turkish population, the Turkish Adults’ Heart Disease and Risk Factors (TEKHARF) study was carried out. The study estimated an annual incidence of 35000 (22000 in females) and a prevalence of 310000.info:eu-repo/semantics/openAccessAtrial fibrillationArticle2828793